retatrutide trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a retatrutide latest trial results Results:

Retatrutide is a synthetic peptide engineered to function as a triple receptor agonist , meaning it interacts with three different metabolic hormone receptors

223 Recently, a study found that alpha-TC1/6 cells can secrete GLP-1 under hyperglycemic, hyperlipidemic or inflammatory conditions during in vitro experiments, suggesting that this hormone may act locally to influence both islet alpha- and beta-cell behaviour during pathological conditions

Hannah S Lyons, University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, B15 2TT, UK

Retrieved from Wharton-a, S., Aronne, L

If you are considering stopping the medication, say so

Now, were learning its entirely possible and maybe even beneficial in the long run for certain people to dial down the dose and microdose their GLP-1